Assessing tumor angiogenesis using macromolecular MR imaging contrast media

Journal of Magnetic Resonance Imaging

Volumn 7, Issue 1, 1997, Pages 68-74

  Brasch, Robert ^a   Pham, Christine ^b   Shames, David ^b   Roberts, Timothy ^b   Van Dijke, Kees ^b   Van Bruggen, Nick ^b   Mann, Jeffry ^b   Ostrowitzki, Susanne ^b   Melnyk, Ostap ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

Angiogenesis; Contrast media; Macromolecular microvascular permeability; MR imaging (MRI); Tumor vascular endothelial growth factor

Indexed keywords

GADOLINIUM PENTETATE ALBUMIN; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; BREAST CARCINOMA; CONTRAST ENHANCEMENT; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; NUDE MOUSE; PRIORITY JOURNAL; REVIEW; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION;

ANIMALS; CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; ENDOTHELIAL GROWTH FACTORS; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; RATS; SENSITIVITY AND SPECIFICITY;

EID: 0031421953     PISSN: 10531807     EISSN: None     Source Type: Journal    
DOI: 10.1002/jmri.1880070110     Document Type: Review

References (40)

1. Folkman J. What is the evidence that tumors are angiogenesis dependent? J Natl Cancer Inst 1989; 82:4-6.
2. Liotta LA, Kleinerman J, Saidel GM. Quantitative relationships of intravascular tumor cells, tumor vessels and pulmonary metastases following tumor implantation. Cancer Res 1974; 34: 997-1004.
3. Jain R, Gerlowski L. Extravascular transport in normal and tumor tissues. Crit Rev Oncol Hematol 1984; 5:115-170.
4. Fidler I, Ellis L. The implication of angiogenesis for the biology and therapy of cancer metastases. Cell 1994; 79:185-188.
5. Weidner N, Semple J, Welch W, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324:1-8.
6. Weidner N. Intratumoral microvascular density as a prognostic factor in cancer. Am J Pathol 1995; 147:9-19.
7. Folkman J. Introduction: angiogenesis and cancer. Semin Cancer Biol 1992; 3:47-48.
8. Heywang-Köbrunner S. Contrast-enhanced magnetic resonance imaging of the breast. Invest Radiol 1994; 29:94-104.
9. Aicher KP, Dupon JW, White DL, et al. Contrast-enhanced magnetic resonance imaging of tumor-bearing mice treated with human recombinant tumor necrosis factor alpha. Cancer Res 1990; 50:7376-7381.
10. van Dijke C, Brasch R, Roberts T, et al. Mammary carcinoma model: correlation of macromolecular contrast enhanced MR imaging characterizations of tumor microvasculature and histologic capillary density. Radiology 1996; 198:813-818.
11. Schwickert H, Stiskal M, Roberts T, et al. Contrast-enhanced MRI assessment of tumor capillary permeability: the effect of pre-irradiation on the tumor delivery of chemotherapy. Radiology 1996; 198:893-898.
12. Cohen F, Kuwatsuru R, Shames D, et al. Contrast enhanced MRI estimation of altered capillary permeability in experimental mammary carcinomas following x-irradiation. Invest Radiol 1995; 29:970-977.
13. Schmiedl U, Ogan MD, Paajanen H, et al. Albumin labeled with Gd-DTPA as an intravascular, blood pool-enhancing agent for MR imaging: biodistribution and imaging studies. Radiology 1987; 162:205-210.
14. Kuwatsuru R, Shames D, Mühler A, et al. Quantification of tissue plasma volume in the rat by contrast-enhanced magnetic resonance imaging. Magn Reson Med 1993; 30:76-81.
15. Schwickert H, Stiskal M, van Dijke C, et al. Tumor angiography using high resolution 3D MRI: comparison of Gd-DTPA and a macromolecular blood pool contrast agent. Acad Radiol 1995; 2:851-858.
16. Price J, Polyzos A, Zhang R, Daniels L. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice. Cancer Res 1990; 50:717-721.
17. Ogan MD, Schmiedl U, Moseley ME, Grodd W, Paajanen H, Brasch RC. Albumin labeled with Gd-DTPA: an intravascular contrast enhancing agent for magnetic resonance blood pool imaging: preparation and characterization. Invest Radiol 1987; 22: 665-671.
18. Schmiedl U, Ogan MD, Moseley ME, Brasch RC. Comparison of the contrast-enhancing properties of albumin-(Gd-DTPA) and Gd-DTPA at 2.0 T: an experimental study in rats. AJR Am J Roentgenol 1986; 147:1263-1270.
19. Kim K, Li B, Houck K, Winer J, Ferrara N. The vascular endothelial growth factor proteins: identification of biologically relevant regions by neutralizing monoclonal antibodies. Growth Factors 1992; 7:53-64.
20. Schwickert H, Roberts T, Shames D, et al. Quantification of liver blood volume: comparison of ULSTIR-EPI, a fast inversion recovery echo-planar approach, with dynamic 3D-SPGR. Magn Reson Med 1995; 34:845-852.
21. Shames D, Kuwatsuru R, Vexler V, Muehler A, Brasch R. Measurement of capillary permeability to macromolecules by dynamic magnetic resonance imaging: a quantitative non-invasive technique. Magn Reson Med 1993; 29:616-622.
22. Renkin EM. Transport of potassium-42 from blood to tissue in isolated mammalian skeletal muscles. Am J Physiol 1959; 197: 1205-1210.
23. Crone C. The permeability of capillaries in various organs determined by the use of the "indicator diffusion" method. Acta Physiol Scand 1963; 58:292-305.
24. Heuser L, Miller F. Differential macromolecular leakage from the vasculature of tumors. Cancer 1986; 57:461-464.
25. Jain R. Transport of molecules across tumor vasculature. Cancer and Metastasis Rev 1987; 6:559-593.
26. Jain R. Vascular and interstitial barriers to delivery of therapeutic agents in tumors. Cancer Metastasis Rev 1990; 9:253-266.
27. Gerlowski LE, Jain RK. Microvascular permeability of normal and neoplastic tissues. Microvas Res 1986; 31:288-305.
28. Kohn S, Nagy J, Dvorak H, Dvorak A. Pathways of macromolecular tracer transport across venules and small veins, structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992; 76:596-607.
29. Dvorak H, Brown L, Detman M, Dvorak A. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 1995; 146: 1029-1039.
30. Wikstrom MG, Moseley ME, White DL, et al. Contrast enhanced MRI of tumors: comparison of Gd-DTPA and a macromolecular agent. Invest Radiol 1989; 24:609-615.
31. Kaiser W, Zeitler E. MR imaging of the breast: fast imaging sequences with and without Gd-DTPA. Radiology 1989; 170: 681-686.
32. Stack JP, Redmond OM, Codd MB, Dervan PA, Ennis JT. Breast disease: tissue characterization with Gd-DTPA enhancement profiles. Radiology 1990; 174:491-494.
33. Buadu L, Murakami J, Murayama S, Hashiguchi N, Masuda K, Toyoshima S. Correlation between contrast-enhanced MR imaging of the breast and tumor angiogenesis: a quantitative and qualitative study. In: Annual Meeting American Roentgen Ray Society. San Diego: American Roentgen Ray Society, 1996; 58.
34. Tofts P, Berkowitz B, Schnall M. Quantitative analysis of dynamic Gd-DTPA enhancement in breast tumors using a permeability model. Magn Reson Med 1995; 33:564-568.
35. Stomper P, Herman S, Klippenstein D, et al. Suspect breast lesions: findings at dynamic gadolinium-enhanced MR imaging correlated with mammographic and pathologic features. Radiology 1995; 197:387-395.
36. Weinreb J, Newstead G. MR imaging of the breast. Radiology 1995; 196:593-610.
37. Spraggins T, de Paredes E, DeAngelis G. Three-dimensional keyhole imaging: application to dynamic contrast-enhanced MRI of the breast. In: Proceedings of the 12th annual meeting of the Society of Magnetic Resonance in Medicine. Berkeley, CA: Society of Magnetic Resonance in Medicine, 1993; 118.
38. Patlak C, Blasberg R, Fenstermacher J. Graphical evaluation of blood-to-brain transfer constants from multiple time uptake data. J Cerebr Blood Flow Metab 1983; 3:1-7.
39. Weinmann H, Laniado M, Mützel W. Pharmacokinetics of Gd-DTPA/dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984; 16:167-72.
40. Schmiedl U, Moseley ME, Ogan MD, Chew WM, Brasch RC. Comparison of initial biodistribution patterns of Gd-DTPA and albumin-Gd-DTPA using rapid spin echo imaging. J Comput Assist Tomogr 1987; 11:306-313.